State of Wisconsin Investment Board’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Other funds holding AKBA
VCM
VPM
State of Wisconsin Investment Board's AKBA Position: Q1 2026 in Review
State of Wisconsin Investment Board sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 13,981 shares — an estimated $22.5K sold.
State of Wisconsin Investment Board first reported a position in AKBA in Q2 2017 and held it in 20 quarters. The position peaked at $2.92M in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.
- State of Wisconsin Investment Board reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
- State of Wisconsin Investment Board sold 13,981 Akebia Therapeutics shares in Q1 2026, an estimated $22.5K.
- State of Wisconsin Investment Board first reported a position in Akebia Therapeutics in Q2 2017 and held it in 20 quarters.
- State of Wisconsin Investment Board's Akebia Therapeutics position peaked at $2.92M in Q2 2020.
- 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.